Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery
PLIN2 and RAB14, but not CK18, are markers for monitoring improvements in MASH and fibrosis after interventions such as bariatric surgery. This may reduce or eliminate the need for frequent liver biopsies. ClinicalTrials.gov Registration Number: NCT03524365.
Authors
- Carel Wynand le Roux (ORCID: https://orcid.org/0000-0001-5521-5445)
- Marco Raffaelli (ORCID: https://orcid.org/0000-0002-1259-2491)
- Royce P Vincent (ORCID: https://orcid.org/0000-0003-0743-4189)
- Matteo Garcovich (ORCID: https://orcid.org/0000-0002-5805-7953)
- Laura Riccardi (ORCID: https://orcid.org/0000-0001-6249-0314)
- Tracey Mare (ORCID: https://orcid.org/0000-0002-5231-375X)
- Ornella Verrastro
- Geltrude Mingrone (ORCID: https://orcid.org/0000-0003-2021-528X)
- Maurizio Pompili (ORCID: https://orcid.org/0000-0001-6699-7980)
- Giulia Angelini (ORCID: https://orcid.org/0000-0001-6753-745X)
- Simona Panunzi (ORCID: https://orcid.org/0000-0003-0956-8578)
- James Luxton
- Sara Russo (ORCID: https://orcid.org/0009-0005-7144-6506)
Institutions
- University College Dublin (IE)
- Università Cattolica del Sacro Cuore (IT)
- King's College London (GB)
- Agostino Gemelli University Polyclinic (IT)
- King's College Hospital NHS Foundation Trust (GB)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto di Analisi dei Sistemi ed Informatica Antonio Ruberti (IT)
Publication Details
- Journal
- Clinical Chemistry
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1093/clinchem/hvae208
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Science Foundation Ireland
- Irish Research Council
- Novo Nordisk